On September 9, 2014 (the Closing Date), Mindesta, Inc. entered into a Share Exchange Agreement with CTT Pharmaceuticals, Inc., f/k/a Fenwafe Inc., and the shareholders of CTT Pharma whereby Mindesta acquired all of the issued and outstanding shares of common stock of CTT Pharma in consideration for the issuance of 149,183,285 shares of Mindesta common stock of which CTT Pharma instructed Mindesta to issue 8,444,337 to Capital Financial. Pursuant to the Share Exchange Agreement at closing the following individuals were appointed as officers and directors of the Company: Dr. Pankaj Modi, Dr. Allen Greenspoon and Dean Hanisch. At the time of Closing, Gregory Bowes tendered his resignation as an officer and director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 USD | +33.78% | 0.00% | +42.86% |
2020 | CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech | CI |
2020 | CTT Pharmaceutical Holdings, Inc. Announces Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
+42.86% | 2.01M | |
+1.51% | 42.75B | |
+49.05% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CTTH Stock
- News CTT Pharmaceutical Holdings, Inc.
- Mindesta, Inc. Announces Executive Changes